Adelpha Abrahamson Larkin

Adelpha Abrahamson Larkin is a seasoned professional in market access, pricing strategy, and healthcare economics with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director/Head, Payer and Pricing Strategy at Day One Biopharmaceuticals since June 2022, Adelpha previously held significant roles at BioMarin Pharmaceutical Inc. and Genentech, where responsibilities included leading access and reimbursement strategies for various high-value therapies. With a strong background in consulting and strategic planning, including previous positions at BioMedical Insights and Decision Resources, Adelpha has successfully developed innovative pricing and contracting approaches, managed cross-functional initiatives, and provided insights that shaped product market strategies across multiple therapeutic areas. Adelpha holds a Bachelor of Arts degree from Clark University.